Published in J Clin Endocrinol Metab on April 16, 2012
Endotoxin and Intestinal Flora Before and After Gastric Bypass or Banding in Diabetics | NCT00960765
Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study. Cereb Cortex (2013) 1.09
Improved memory function two years after bariatric surgery. Obesity (Silver Spring) (2013) 1.08
Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. Front Neurosci (2015) 0.94
Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function. J Clin Neurol (2015) 0.83
The Association Between Reduced Inflammation and Cognitive Gains After Bariatric Surgery. Psychosom Med (2015) 0.83
Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus. Br J Pharmacol (2014) 0.78
Surgical and Nonsurgical Interventions for Obesity in Service of Preserving Cognitive Function. Psychosom Med (2015) 0.78
Family history of Alzheimer's disease limits improvement in cognitive function after bariatric surgery. SAGE Open Med (2014) 0.77
Older age does not limit postbariatric surgery cognitive benefits: a preliminary investigation. Surg Obes Relat Dis (2014) 0.77
Leptin and aging. Aging (Albany NY) (2014) 0.77
The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms. Curr Diab Rep (2014) 0.76
Intrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity. Biochim Biophys Acta (2016) 0.75
Pre-operative history of depression and cognitive changes in bariatric surgery patients. Psychol Health Med (2014) 0.75
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78
Alzheimer's disease. Lancet (2011) 5.35
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol (2004) 5.11
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol (2011) 4.76
Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care (2009) 2.83
Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res (2010) 2.04
The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab (2001) 1.77
Improved memory function 12 weeks after bariatric surgery. Surg Obes Relat Dis (2010) 1.62
An overview of APP processing enzymes and products. Neuromolecular Med (2010) 1.54
beta-Amyloid degradation and Alzheimer's disease. J Biomed Biotechnol (2006) 1.35
GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol (2009) 1.32
Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr Alzheimer Res (2008) 1.12
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-Fos. Eur J Biochem (1999) 0.92
Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner. PLoS One (2010) 0.91
Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice. Neurobiol Aging (2008) 0.90
Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells. J Clin Endocrinol Metab (2011) 0.88
Epigenetic reprogramming in mammals. Hum Mol Genet (2005) 6.73
Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation (2004) 3.17
Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes (2003) 3.00
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab (2004) 2.93
Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care (2009) 2.83
Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab (2004) 2.36
Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke (2005) 2.24
Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr (2010) 1.85
Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care (2010) 1.61
Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care (2010) 1.60
Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr (2004) 1.57
Sitagliptin exerts an antinflammatory action. J Clin Endocrinol Metab (2012) 1.55
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Endocr Pract (2015) 1.52
An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab (2010) 1.48
Acute modulation of toll-like receptors by insulin. Diabetes Care (2008) 1.46
Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation (2004) 1.46
Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care (2007) 1.46
Epigenetic dynamics of the Kcnq1 imprinted domain in the early embryo. Development (2006) 1.38
Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab (2007) 1.38
Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab (2011) 1.37
Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab (2002) 1.35
Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin. Endocr Pract (2007) 1.35
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care (2002) 1.35
A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab (2011) 1.35
Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr (2002) 1.19
Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care (2006) 1.18
Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism (2004) 1.17
Liraglutide as additional treatment for type 1 diabetes. Eur J Endocrinol (2011) 1.15
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab (2003) 1.13
Testosterone concentration in young patients with diabetes. Diabetes Care (2008) 1.11
Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care (2006) 1.11
Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab (2006) 1.04
Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care (2010) 1.03
Durability of effects of exenatide treatment on glycemic control, body weight, systolic blood pressure, C-reactive protein, and triglyceride concentrations. Endocr Pract (2011) 1.01
Comparative evaluation of adjunctive oral irrigation in diabetics. J Clin Periodontol (2002) 1.00
Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. J Neurosurg (2011) 1.00
A high-carbohydrate diet in the immediate postnatal life of rats induces adaptations predisposing to adult-onset obesity. J Endocrinol (2008) 0.98
Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North Carolina. AIDS Behav (2009) 0.98
Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism (2002) 0.95
Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab (2012) 0.95
Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol (2009) 0.95
Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf) (2013) 0.94
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. Diabetes Care (2003) 0.93
Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus. Endocr Pract (2013) 0.93
Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care (2011) 0.93
Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. Endocrine (2012) 0.91
Proinflammatory and prothrombotic effects of hypoglycemia. Diabetes Care (2010) 0.91
The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care (2007) 0.91
Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. Curr Drug Targets (2003) 0.90
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism. Atherosclerosis (2012) 0.89
Translocation of p47phox and activation of NADPH oxidase in mononuclear cells. Methods Mol Biol (2002) 0.89
Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2012) 0.88
Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells. J Clin Endocrinol Metab (2011) 0.88
Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss. Obesity (Silver Spring) (2013) 0.87
Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individuals. Br J Nutr (2011) 0.87
Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood. Atherosclerosis (2013) 0.86
Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. Hum Reprod (2012) 0.86
Maternal obesity and fetal programming: effects of a high-carbohydrate nutritional modification in the immediate postnatal life of female rats. Am J Physiol Endocrinol Metab (2008) 0.85
Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors. Endocr Pract (2012) 0.84
Free fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation. --to: Steinberg et al. (2002) Vascular function, insulin resistance and fatty acids. Diabetologia (2003) 0.84
Lipid hydroperoxide-induced tumor necrosis factor (TNF)-alpha, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition. Angiogenesis (1998) 0.83
Lipids, carbohydrates, and heart disease. Metab Syndr Relat Disord (2003) 0.82
Susceptibility to fatty acid-induced β-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: a potential link between β-cell lipotoxicity and islet inflammation. Endocrinology (2012) 0.82
Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Am J Physiol Endocrinol Metab (2013) 0.82
Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus. Endocr Pract (2008) 0.81
Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial. Metabolism (2004) 0.81
A novel view of metabolic syndrome. Metab Syndr Relat Disord (2004) 0.81
Acute myocardial infarction, hyperglycemia, and insulin. J Am Coll Cardiol (2009) 0.81
Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 0.81
Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction. Am J Cardiol (2007) 0.80
Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ (2005) 0.80
Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis. Diabetes Metab Res Rev (2012) 0.80
Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment. J Clin Endocrinol Metab (2005) 0.80